Filter
9875
Filtered Results: 9875
Text search:
patiente
care
Featured
Recommendations
1001
New Publications
2322
Language
Document type
No document type
5317
Guidelines
1559
Studies & Reports
1382
Manuals
530
Strategic & Response Plan
294
Fact sheets
284
Training Material
195
Situation Updates
113
Infographics
55
Resource Platforms
50
Brochures
47
Online Courses
33
Videos
14
Dashboards/Maps
1
App
1
Countries / Regions
India
475
Global
329
South Africa
257
Kenya
237
Sierra Leone
224
Liberia
213
Western and Central Europe
190
Latin America and the Carribbean
173
Nigeria
167
Ethiopia
164
Uganda
158
Africa
152
Malawi
123
Tanzania
119
Nepal
115
Rwanda
114
Congo, Democratic Republic of
107
Zambia
106
Syria
102
Germany
100
Bangladesh
100
Brazil
99
Ghana
97
Ukraine
95
Myanmar / Burma
94
Russia
94
Guinea
80
Eastern Europe
77
Senegal
72
Namibia
71
Philippines
67
Mozambique
66
Burkina Faso
65
Haiti
62
Indonesia
62
West and Central Africa
60
South–East Asia Region
53
Cambodia
52
East and Southern Africa
52
Middle East and North Africa
52
Venezuela
52
Zimbabwe
51
South Sudan
51
Lesotho
50
Asia
47
Colombia
44
Eastern Europe and Central Asia
41
Cameroon
40
Benin
37
Yemen
37
Argentina
36
Peru
35
Botswana
33
Mali
31
Paraguay
29
Madagascar
28
Chile
28
Eswatini/ Swaziland
26
Ecuador
26
Côte d’Ivoire / Ivory Coast
24
USA
24
Angola
24
El Salvador
22
Bolivia
21
Western Pacific Region
19
Spain
17
Pakistan
16
Central African Republic
16
Guinea-Bissau
15
Sudan
15
Tajikistan
15
Vietnam
15
Iraq
14
Somalia
13
Afghanistan
13
Thailand
12
Niger
11
Chad
11
Sri Lanka
11
Albania
11
Laos
11
Georgia
11
Jordan
10
Lebanon
10
United Kingdom
10
Togo
9
China
9
Mexico
9
Palestine
9
Southern Africa
9
Moldova
9
Honduras
8
North America
8
Guatemala
7
Saudi Arabia
6
Turkey
6
North Macedonia
6
Switzerland
6
Armenia
6
Burundi
5
Nicaragua
5
Bhutan
5
Italy
5
Canada
5
Kazakhstan
5
Jamaica
5
France
5
Gambia
4
Ireland
4
Papua New Guinea
4
Hungary
4
Libya
4
Poland
4
Romania
4
Kyrgyzstan
4
Egypt
3
Singapore
3
Serbia
3
Greece
3
Congo-Brazzaville
3
Timor Leste/ East Timor
3
Estonia
3
Uruguay
3
Mauritius
3
Portugal
3
Morocco
2
Malaysia
2
Austria
2
Other region
2
Fiji
2
Bulgaria
2
Lithuania
2
Slovakia
2
Iran
2
Uzbekistan
2
Australia
2
Belgium
2
Mauritania
1
Dominican Republic
1
Cuba
1
Luxembourg
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Norway
1
South Korea
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3626
Clinical Guidelines
902
Public Health
516
Women & Child Health
406
Key Resources
313
Capacity Building
214
Pharmacy & Technologies
121
Annual Report MEDBOX
2
Toolboxes
COVID-19
1260
Mental Health
836
TB
699
HIV
687
Ebola
458
Caregiver
431
AMR
331
Rapid Response
293
NTDs
241
NCDs
239
Conflict
207
Pharmacy
205
Disability
198
Refugee
186
Planetary Health
143
Global Health Education
104
Natural Hazards
74
Cholera
71
Zika
68
Specific Hazards
49
Social Ethics
49
Polio
44
Health Financing Toolbox
40
Typhoon
3
South Sudan
1
Health Financing
1
The present DHR-ICMR guidelines comprehensively address the various concerns regarding the clinical assessment, treatment, and laboratory diagnosis of rickettsial diseases in India and the world. It is hoped that physicians, health care workers, the...
The Hand Hygiene Self-Assessment Framework is a systematic tool with which to obtain a situation analysis of hand hygiene promotion and practices within an individual health-care facility.
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients and TB diagnosis in HIV .... Early detection and effective treatment are essential to preventing TB-associated deaths.
WHO and UNAIDS have strongly advised countries to ensure that HIV programmes integrate regular TB screening, preventive therapy and early treatment.
Large-Scale UN Response Needed to Address Health and Food Crises
This report is based on interviews with more than 150 health care professionals, Venezuelans seeking or in need of medical care who ...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
Outline
• Welcome and objectives
• Microbiology, epidemiology and clinical presentation
• Surveillance for imported cases including case definitions
• Laboratory diagnosis • Infection prevention and hospital readiness
• Patient ...
Guide de Mise en Œuvre de la Stratégie multimodale de l’OMS pour la Promotion de l’Hygiène des Mains
Les infections associées aux soins (IAS) constituent une menace sérieuse dont l’impact économique pour les patients et les systèmes de santé dans le monde entier est significatif. Pourtant, la pratique de l’hygiène des mains – le simple ...
Recommended practices booklet (April 2020)
The set includes 10 Counselling Cards and a Recommended Practices Booklet. Infant and young child feeding (IYCF) counselling in the context of COVID-19 remains a critical nutrition intervention for the protection and support of pregnant women, ...givers, and their young children. WHO and UNICEF advise caregivers and families with suspected or confirmed COVID-19 to continue the recommended IYCF practices with the necessary hygiene precautions. It is therefore vital to ensure that communities and families around the world adopt these recommendations to help prevent the spread of the virus and care for those who are infected.
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, pati... monitors, thermometers, infusion and suction pumps, X-ray, ultrasound and CT scanners as well as personal protective equipment. In order to facilitate access to quality assured priority medical devices, the document also includes technical and performance characteristics, related standards, accessories and consumables. It is intended for policy-makers and planning officers in Ministries of Health, procurement and regulatory agencies, intergovernmental and international agencies as well as the medical device industry.
This document is an update to the List of priority medical devices for COVID-19 case management and Technical specifications for invasive and non-invasive ventilators for COVID-19.
This document complements the Technical specifications of personal protective equipment for COVID-19.
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, pati... monitors, thermometers, infusion and suction pumps, X-ray, ultrasound and CT scanners as well as personal protective equipment. In order to facilitate access to quality assured priority medical devices, the document also includes technical and performance characteristics, related standards, accessories and consumables. It is intended for policy-makers and planning officers in Ministries of Health, procurement and regulatory agencies, intergovernmental and international agencies as well as the medical device industry.
This document is an update to the List of priority medical devices for COVID-19 case management and Technical specifications for invasive and non-invasive ventilators for COVID-19.
This document complements the Technical specifications of personal protective equipment for COVID-19.
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous and Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in ...
Assessment of non-communicable diseases (NCDs) service disruptions during the COVID-19 pandemic. Preliminary results.
Guidance on how to provide continuity for NCD programmes:• How to include NCDs in public health emergencies protocols?• How to develop national NCDs tool kits for use in emergen...
The Ideal Clinic Realisation and Maintenance (ICRM) programme was initiated by the National Department of Health in July 2013 in order to systematically improve primary health care (PHC) facilities and the quality of ... they provide. The Ideal Clinic framework/dashboard sets out the standards for PHC facilities to provide good-quality health services. An Ideal Clinic is defined as a clinic with good infrastructure, adequate staff, adequate medicines and supplies, good administrative processes, and sufficient adequate bulk supplies. Applicable clinical policies, protocols and guidelines are adhered to, and it harnesses partner and stakeholder support.
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in ... 6 years of age and older and weighing at least 20 kg.
Limitations of Use
Due to the decreased efficacy observed in patients with severe second stage HAT (cerebrospinal fluid white blood cell count (CSF-WBC) >100 cells/μL) due to T. brucei gambiense disease, Fexinidazole Tablets should only be used in these patients if there are no other available treatment options [see Warnings and Precautions (5.1)]
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health ... provider and do not receive the necessary care in a timely fashion. Without rapid detection of danger signs and access to effective treatment, including pre-referral treatment that can be administered in the community level, many of these children with severe malaria die.
In situations where there is no immediate access to a health care facility, WHO recommends the administration of a standard dose of an effective antimalarial medicine as pre-referral treatment before referral to a facility at which complete treatment can be administered.
Rectal artesunate is the WHO-recommended pre-referral intervention in situations where artesunate injection are not feasible for children under the age of 6 years with suspected severe malaria. The intervention reduces the risk of death or permanent disability by up to 50% provided the child is referred to a health facility at which complete treatment can be administered.
This field guide is aimed at supporting the effective deployment of RAS as pre-referral treatment of suspected severe malaria in line with the WHO malaria guidelines.
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in ... with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
Objective: To identify gaps in national stroke guidelines that could be bridged to enhance the quality of stroke care services in low- and
middle-income countries.
Methods: We systematically searched medical databases and websites of medical socie...
How to Recognise and Manage Leprosy Reactions
recommended
This book is for all health workers who may have to help people who have nerve damage to their eyes, hands and feet. It will help them to encourage patients to develop a lifetime habit of caring for nerve-damaged parts.
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, tre...
The guidelines begin with an overview of the determinants of mental health among children and adolescents before reviewing related South African policies and legislation. The document then discusses strategies to build skills among caregivers, teach...
